CHEPLIAKA, OLEKSII;INVENRES GMBH;GERASHCHENKO, IGOR
发明人:
IGOR GERASHCHENKO,OLEKSII CHEPLIAKA
申请号：
ARP140104181
公开号：
AR098333A1
申请日:
2014.11.06
申请国别(地区):
AR
年份:
2016
代理人:
摘要：
The components of the powder include highly dispersed silicon particles, polymethylsiloxane particles, conductive surfactant and an anti microbial substance, At least 25% by weight of the primary polysilicon particles and / or these primary particle groups with ionic surface tension activity on the surface,Moreover, at least 25% of the antimicrobial substances are present in the main high dispersion silica particles by weight, which have antimicrobial substances on their surfaces and / or aggregate on these primary particles. 3. Claim 3: powder composition, including: 21.0-75.0% by weight of high dispersion silica； 16.0-70.0% by weight of polymethylidene silica； at least one conductive surfactant, 0.2-4.0% by weight； and one 0.5-10% antibacterial substance, 0.5-10% by weight；In addition, there is at least one preparation: at least one tissue growth active substance has a weight percentage of 0.01-10.0%, lidocaine has a weight percentage of 0.01-5.0%, at least one phenyl derivative has a weight percentage of 0.01-5.0%, and at least one protein enzyme has a weight percentage of 0.01-3.0%. Requirement 4: a procedure for the production of powdery components, comprising steps (a) to (c): (a) the proportion of highly dispersed silica particles, polydimethylsiloxane particles, and / or one or two antibiotic surfactants, And an antimicrobial substance；(b) Perform at least one of the following steps (B1) and (B2): (B1) form primary polymethylsilicon particles with ionic surface tension activity on the surface and / or these primary particle polymers (B2) form major high dispersion silicon particles containing the substance Due to the low utilization of high dispersion silica particles, the antimicrobial agents on their surfaces and / or the polymers of these primary particles,(c) Mix most of the high dispersion silica particles with the product (b) passed. Claim 17: composition of any one of claims 1 to 3, 6, 7, 13 or 14, or composition of pharmaceutical preparations for th
